-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – QR-0561 in Idiopathic Pulmonary Fibrosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. QR-0561 in Idiopathic Pulmonary Fibrosis Drug Details: QR-0561 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – QR-0561 in Idiopathic Pulmonary Fibrosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.QR-0561 in Idiopathic Pulmonary Fibrosis Drug Details: QR-0561 is under development for the treatment of idiopathic...
-
Sector Analysis
New![]()
Thailand Cards and Payments – Opportunities and Risks to 2027
Thailand Cards and Payments Market Report Overview The annual value of card transactions in the Thailand cards and payments market is estimated to be $62.5 billion in 2023 and is expected to grow at a CAGR of more than 7% during 2023-2027. To encourage the adoption of cashless payments, the government and payment providers are increasingly pushing QR code-based mobile payments as an alternative to cash. Thailand Card Transactions Outlook, 2023-2027 ($ Billion) Buy the Full Report for More Information...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HIP-0612 in Gastric Ulcers
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. HIP-0612 in Gastric Ulcers Drug Details: HIP-0612 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy For Oncology 1 in Bile Duct Cancer (Cholangiocarcinoma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cellular Immunotherapy For Oncology 1 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details:Cellular immunotherapy is under investigation...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ABBV-927 in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-927 in Non-Small Cell Lung Cancer Drug Details: ABBV-927 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Racemetyrosine in Hormone Sensitive Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Racemetyrosine in Hormone Sensitive Breast Cancer Drug Details: Racemetyrosine (SM-88) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Eribulin Mesylate in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eribulin mesylate in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drug Details: Eribulin mesylate (E-7389, Halaven,Teceris)...
-
Company Insights
![]()
Octopus – Competitor Profile
Octopus Wallet is a digital payment brand based in Hong Kong (China SAR). Launched in April 2016 as O! ePay, it was rebranded as Octopus Wallet in November 2020. It can be used for both online and in-store payments. Funds can be loaded to the wallet via mobile banking apps, Hong Kong (China SAR)’s Faster Payment System (FPS) instant payment solution, Octopus Card, and in cash at partner merchants. Octopus Wallet has three versions: Lite, Plus, and Pro. These versions...
-
Company Insights
![]()
Tenpay – Competitor Profile
Tenpay is one of the most the popular alternative payment solutions in China. It was launched in 2005 by Tencent – one of China’s leading internet companies. Tenpay supports online, in-app, and in-store payments both in China and abroad. Tenpay users can make fund transfers to other users’ Tenpay accounts or their bank accounts. Users can also make mortgage and credit card payments and can invest in various financial products. Tencent also owns popular social media platforms including QQ Messenger...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.